- Wolfspeed, Inc. WOLF rose 20.7% to $103.40 in pre-market trading after the company reported better-than-expected Q4 results.
- bluebird bio, Inc. BLUE shares rose 13.5% to $7.70 in pre-market trading. The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
- ReneSola Ltd SOL gained 10.4% to $7.00 in pre-market trading. ReneSola is expected to report its unaudited financial results for the second quarter on Wednesday, September 7, 2022.
- Privia Health Group, Inc. PRVA rose 9.7% to $39.40 in pre-market trading. Privia Health, last week, said Q2 EPS results were higher year over year.
- Grindrod Shipping Holdings Ltd. GRIN rose 9.3% to $20.95 in pre-market trading. Grindrod Shipping reported a second-quarter revenue increase of 47.1% year-over-year to $161.58 million.
- TORM plc TRMD gained 6.7% to $20.86 in pre-market trading.
- Ultragenyx Pharmaceutical Inc. RARE rose 5.7% to $49.94 in pre-market trading. Ultragenyx reported inducement grant under Nasdaq Listing Rule 5635(c)(4).
- Keysight Technologies, Inc. KEYS rose 4.4% to $176.72 in pre-market trading as the company reported upbeat earnings for its third quarter and issued a strong forecast for the fourth quarter.
- Cisco Systems, Inc. CSCO rose 4.2% to $48.62 in pre-market trading after the company reported better-than-expected results for its fourth quarter and issued strong guidance.
Also check this out: U.S. Jobless Claims And Existing Home Sales Among Biggest Macro Catalysts Today .
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in